At Skyhawk Therapeutics we use proprietary structural, kinetic, and computational models to invent small molecules that correct splicing in RNA, targeting some of the world’s most intractable diseases.
Meet the team hiring for Skyhawk’s “BIOTE
Feb 25, 2022 | 11:00 AM
Event Categories: